Drug Shortage Report for RIVA-LATANOPROST
Report ID | 161818 |
Drug Identification Number | 02341085 |
Brand name | RIVA-LATANOPROST |
Common or Proper name | Riva-Latanoprost opht.50mcg / ml 2.5ml |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LATANOPROST |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 2.5 ml |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-06-10 |
Actual start date | 2022-08-05 |
Estimated end date | 2022-10-31 |
Actual end date | 2022-11-18 |
Shortage status | Resolved |
Updated date | 2023-05-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-02 | French | Compare |
v6 | 2023-05-02 | English | Compare |
v5 | 2022-08-16 | French | Compare |
v4 | 2022-08-16 | English | Compare |
v3 | 2022-06-11 | English | Compare |
v2 | 2022-06-03 | French | Compare |
v1 | 2022-06-03 | English | Compare |
Showing 1 to 7 of 7